Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Stephens

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Blood|October 6, 2005
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disordersLinda M Scott, Peter J Campbell, E Joanna Baxter, et al.
The Oncologist|April 9, 2014
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practiceNeil Vasan, Roman Yelensky, Kai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2005
A survey of homozygous deletions in human cancer genomesCharles Cox, Graham Bignell, Chris Greenman, et al.
Cancer Research|November 20, 2002
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasiaSiu T Yuen, Helen Davies, Tsun L Chan, et al.
JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Molecular Cancer Therapeutics|September 26, 2014
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agentsPrasanth Ganesan, Stacy Moulder, J Jack Lee, et al.
BMJ Open|October 17, 2019
<i>H</i>igh-flow oxygen for children's <i>a</i>irway surgery: rando<i>m</i>i<i>s</i>ed controll<i>e</i>d <i>t</i>rial protocol (HAMSTER)Susan Humphreys, Britta Sylvia von Ungern-Sternberg, Justin Skowno, et al.
Genomics|January 13, 2006
High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparisonHelen Davies, Ed Dicks, Philip Stephens, et al.
The Lancet. Respiratory Medicine|May 24, 2024
High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trialSusan Humphreys, Britta S von Ungern-Sternberg, Fiona Taverner, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Blood|October 6, 2005
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disordersLinda M Scott, Peter J Campbell, E Joanna Baxter, et al.
The Oncologist|April 9, 2014
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practiceNeil Vasan, Roman Yelensky, Kai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2005
A survey of homozygous deletions in human cancer genomesCharles Cox, Graham Bignell, Chris Greenman, et al.
Cancer Research|November 20, 2002
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasiaSiu T Yuen, Helen Davies, Tsun L Chan, et al.
JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Molecular Cancer Therapeutics|September 26, 2014
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agentsPrasanth Ganesan, Stacy Moulder, J Jack Lee, et al.
BMJ Open|October 17, 2019
<i>H</i>igh-flow oxygen for children's <i>a</i>irway surgery: rando<i>m</i>i<i>s</i>ed controll<i>e</i>d <i>t</i>rial protocol (HAMSTER)Susan Humphreys, Britta Sylvia von Ungern-Sternberg, Justin Skowno, et al.
Genomics|January 13, 2006
High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparisonHelen Davies, Ed Dicks, Philip Stephens, et al.
The Lancet. Respiratory Medicine|May 24, 2024
High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trialSusan Humphreys, Britta S von Ungern-Sternberg, Fiona Taverner, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
Pageof 4